The Developing Life Sciences Ecosystem is Driving Changes in the Profile of Boards

Pharma IQ

As biotech/emerging companies develop and their assets/operations approach commercial maturity we see a change in the skill mix sought by Chairs. o It is unsurprising that 70% of those surveyed say that knowledge of the Life Sciences industry is essential. o In recent years it has become apparent to us that commercialisation experience is a crucial part of the skill mix for a Life Sciences Board- 58% of our survey agrees. o As open Innovation rises and in-house generated pipelines con...
To continue reading this story get free access